Clinical Efficacy and Safety of High-Dose Dexamethasone Plus Low-Dose Rituximab as First-Line Therapy in Newly Diagnosed Primary Immune Thrombocytopenia

Standard-dose prednisone as first-line therapy for primary immune thrombocytopenia (ITP) can not obtain high long-term responses. Results from high-dose dexamethasone course administered in adult newly diagnosed ITP were promising. The role of standard-dose rituximab in first-line treatment of newly...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Indian J Hematol Blood Transfus
Hlavní autoři: Zhou, Hu, Liu, Liu, Shu, Xinhui, Wang, Xiaoran, Song, Yongping
Médium: Artigo
Jazyk:Inglês
Vydáno: Springer India 2019
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6646487/
https://ncbi.nlm.nih.gov/pubmed/31388265
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12288-018-1061-7
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky